Authors : Kashish Tiwari

Volume/Issue : Volume 10 - 2025, Issue 5 - May

Google Scholar : https://tinyurl.com/2nprc9a9

Scribd : https://tinyurl.com/ycy3u3pz

DOI : https://doi.org/10.38124/ijisrt/25may224

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Abstract : Humans and animals often lose tissues and organs due to congenital defects, injuries, and diseases. Unlike urodele amphibians, such as salamanders, which have remarkable regenerative abilities, the human body has limited capacity for tissue regeneration. Across the world, millions of individuals could greatly benefit if tissues and organs could be generated on demand. Traditionally, transplantation has been the primary approach for replacing damaged or diseased body parts. However, the heavy reliance on organ donation has resulted in long waiting lists, with demand far exceeding supply. The societal costs of caring for patients with organ failure and debilitating conditions are immense. In response to this challenge, scientists and clinicians are working to develop safe and reliable methods for generating tissues and organs. Advances in regenerative medicine and tissue engineering—disciplines that integrate engineering and biological principles—are making it possible to restore or even create new tissues and organs. One of the most groundbreaking innovations in these fields is three-dimensional (3D) bioprinting, which has the potential to transform regenerative medicine by enabling the fabrication of artificial tissues and organs. This review explores how recent developments in regenerative medicine and tissue engineering are advancing 3D bioprinting and how 3D bioprinting, in turn, is driving progress in these fields. However, before this revolutionary technology can be widely adopted to produce functional, organ-like constructs for regenerative medicine, several significant challenges must be addressed.

References :

1. Pati F, Jang J, Ha D-H, Won Kim S, Rhie J-W, Shim J-H, et al. Patient-specific bioinks for 3D bioprinting of tissue engineering scaffolds. Biomaterials. 2018 Apr;112:264–74.
2. Shah A, Patil D, Makwana S, Basu B. Biomaterials and scaffolds for tissue engineering: Principles and advances. Bioactive Materials. 2024;31:95–123.
3. Kim JH, Jung Y, Kim SH, Sun K. The use of hydrogels in bioprinting for tissue engineering. Tissue Eng Regen Med. 2010;7(1):1–10.
4. Temenoff JS, Mikos AG. Review: Tissue engineering for regeneration of articular cartilage. Biomaterials. 2000 Aug;21(5):431–40.
5. Chimene D, Lennox KK, Kaunas RR, Gaharwar AK. Advanced Bioinks for 3D Printing: A Materials Science Perspective. Ann Biomed Eng. 2016;44(6):2090–102.
6. Mandrycky C, Wang Z, Kim K, Kim D-H. 3D bioprinting for engineering complex tissues. Biotechnol Adv. 2016;34(4):422–34.
7. Mikos AG, Langer R. Chapter 3 - Principles of tissue engineering. In: Atala A, Lanza R, Mikos AG, Nerem R, editors. Principles of Regenerative Medicine. 3rd ed. Elsevier; 2024. p. 33–50.
8. Ferris CJ, Gilmore KJ, Beirne S, McCallum D, Wallace GG. Biofabrication: An overview of the approaches used for printing of living cells. Reprod Biomed Online. 2023;47(6):743–59.
9. Díaz-García A, Soria-Castro R, González-Pérez O. 3D bioprinting for neural tissue engineering: Recent advances and future directions. Front Neurosci. 2024.